APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Anesthetics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global General Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchGeneral Anesthetics Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anesthetics Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal General Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anesthetics Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anesthetics Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global General Anesthetics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of General Anesthetics include Eisai, Johnson & Johnson, Merck, Jiangsu Hengrui Pharmaceutical Co., Ltd., GlaxoSmithKline, Fresenius Kabi AG, Baxter International, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global General Anesthetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of General Anesthetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents General Anesthetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the General Anesthetics market size, projected growth trends, production technologies, key applications, and end-use industries.

General Anesthetics Segment by Company

Eisai

Johnson & Johnson

Merck

Jiangsu Hengrui Pharmaceutical Co., Ltd.

GlaxoSmithKline

Fresenius Kabi AG

Baxter International

AbbVie

AstraZeneca

Lannett

Hikma Pharmaceuticals

Endo International

Boehringer Ingelheim

B. Braun Melsungen AG

Aspen Pharmacare

Abbott Laboratories

General Anesthetics Segment by Type

Inhalation Anesthestic

Intravenous Anesthestic

General Anesthetics Segment by Application

Hospital

Ambulatory Surgery Center

Others

General Anesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the General Anesthetics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of General Anesthetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of General Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of General Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. General Anesthetics Industry Trends Table 2. General Anesthetics Industry Drivers Table 3. General Anesthetics Industry Opportunities and Challenges Table 4. General Anesthetics Industry Restraints Table 5. Global General Anesthetics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global General Anesthetics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global General Anesthetics Sales by Manufacturers (k units) & (2021-2026) Table 8. Global General Anesthetics Sales Market Share by Manufacturers Table 9. Global General Anesthetics Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global General Anesthetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global General Anesthetics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global General Anesthetics Manufacturers, Product Type & Application Table 13. Global General Anesthetics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global General Anesthetics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inhalation Anesthestic Table 17. Major Manufacturers of Intravenous Anesthestic Table 18. Global General Anesthetics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global General Anesthetics Sales by Type (2021-2026) & (k units) Table 20. Global General Anesthetics Sales by Type (2027-2032) & (k units) Table 21. Global General Anesthetics Sales Market Share by Type (2021-2026) Table 22. Global General Anesthetics Sales Market Share by Type (2027-2032) Table 23. Global General Anesthetics Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global General Anesthetics Revenue by Type (2021-2026) & (k units) Table 25. Global General Anesthetics Revenue by Type (2027-2032) & (k units) Table 26. Global General Anesthetics Revenue Market Share by Type (2021-2026) Table 27. Global General Anesthetics Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Ambulatory Surgery Center Table 30. Major Manufacturers of Others Table 31. Global General Anesthetics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global General Anesthetics Sales by Application (2021-2026) & (k units) Table 33. Global General Anesthetics Sales by Application (2027-2032) & (k units) Table 34. Global General Anesthetics Sales Market Share by Application (2021-2026) Table 35. Global General Anesthetics Sales Market Share by Application (2027-2032) Table 36. Global General Anesthetics Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global General Anesthetics Revenue by Application (2021-2026) & (k units) Table 38. Global General Anesthetics Revenue by Application (2027-2032) & (k units) Table 39. Global General Anesthetics Revenue Market Share by Application (2021-2026) Table 40. Global General Anesthetics Revenue Market Share by Application (2027-2032) Table 41. Global General Anesthetics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global General Anesthetics Sales by Region (2021-2026) & (k units) Table 43. Global General Anesthetics Sales Market Share by Region (2021-2026) Table 44. Global General Anesthetics Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global General Anesthetics Sales Forecasted Market Share by Region (2027-2032) Table 46. North America General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America General Anesthetics Sales by Country (2021-2026) & (k units) Table 48. North America General Anesthetics Sales by Country (2027-2032) & (k units) Table 49. Europe General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe General Anesthetics Sales by Country (2021-2026) & (k units) Table 51. Europe General Anesthetics Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific General Anesthetics Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific General Anesthetics Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa General Anesthetics Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa General Anesthetics Sales by Country (2027-2032) & (k units) Table 58. Global General Anesthetics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global General Anesthetics Revenue by Region (2021-2026) & (US$ Million) Table 60. Global General Anesthetics Revenue by Region (2027-2032) & (US$ Million) Table 61. Global General Anesthetics Revenue Market Share by Region (2021-2026) Table 62. Global General Anesthetics Revenue Market Share by Region (2027-2032) Table 63. Eisai Company Information Table 64. Eisai Business Overview Table 65. Eisai General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Eisai General Anesthetics Product Portfolio Table 67. Eisai Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson & Johnson General Anesthetics Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck General Anesthetics Product Portfolio Table 77. Merck Recent Development Table 78. Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information Table 79. Jiangsu Hengrui Pharmaceutical Co., Ltd. Business Overview Table 80. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Product Portfolio Table 82. Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline General Anesthetics Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Fresenius Kabi AG Company Information Table 89. Fresenius Kabi AG Business Overview Table 90. Fresenius Kabi AG General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Fresenius Kabi AG General Anesthetics Product Portfolio Table 92. Fresenius Kabi AG Recent Development Table 93. Baxter International Company Information Table 94. Baxter International Business Overview Table 95. Baxter International General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Baxter International General Anesthetics Product Portfolio Table 97. Baxter International Recent Development Table 98. AbbVie Company Information Table 99. AbbVie Business Overview Table 100. AbbVie General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. AbbVie General Anesthetics Product Portfolio Table 102. AbbVie Recent Development Table 103. AstraZeneca Company Information Table 104. AstraZeneca Business Overview Table 105. AstraZeneca General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. AstraZeneca General Anesthetics Product Portfolio Table 107. AstraZeneca Recent Development Table 108. Lannett Company Information Table 109. Lannett Business Overview Table 110. Lannett General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Lannett General Anesthetics Product Portfolio Table 112. Lannett Recent Development Table 113. Hikma Pharmaceuticals Company Information Table 114. Hikma Pharmaceuticals Business Overview Table 115. Hikma Pharmaceuticals General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hikma Pharmaceuticals General Anesthetics Product Portfolio Table 117. Hikma Pharmaceuticals Recent Development Table 118. Endo International Company Information Table 119. Endo International Business Overview Table 120. Endo International General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Endo International General Anesthetics Product Portfolio Table 122. Endo International Recent Development Table 123. Boehringer Ingelheim Company Information Table 124. Boehringer Ingelheim Business Overview Table 125. Boehringer Ingelheim General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Boehringer Ingelheim General Anesthetics Product Portfolio Table 127. Boehringer Ingelheim Recent Development Table 128. B. Braun Melsungen AG Company Information Table 129. B. Braun Melsungen AG Business Overview Table 130. B. Braun Melsungen AG General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. B. Braun Melsungen AG General Anesthetics Product Portfolio Table 132. B. Braun Melsungen AG Recent Development Table 133. Aspen Pharmacare Company Information Table 134. Aspen Pharmacare Business Overview Table 135. Aspen Pharmacare General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Aspen Pharmacare General Anesthetics Product Portfolio Table 137. Aspen Pharmacare Recent Development Table 138. Abbott Laboratories Company Information Table 139. Abbott Laboratories Business Overview Table 140. Abbott Laboratories General Anesthetics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Abbott Laboratories General Anesthetics Product Portfolio Table 142. Abbott Laboratories Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. General Anesthetics Distributors List Table 146. General Anesthetics Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. General Anesthetics Product Image Figure 2. Global General Anesthetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anesthetics Market Size (2021-2032) & (US$ Million) Figure 4. Global General Anesthetics Sales (2021-2032) & (k units) Figure 5. Global General Anesthetics Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 General Anesthetics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inhalation Anesthestic Image Figure 9. Intravenous Anesthestic Image Figure 10. Global General Anesthetics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global General Anesthetics Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global General Anesthetics Sales Market Share by Type (2021-2032) Figure 13. Global General Anesthetics Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global General Anesthetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global General Anesthetics Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Ambulatory Surgery Center Image Figure 18. Others Image Figure 19. Global General Anesthetics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global General Anesthetics Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global General Anesthetics Sales Market Share by Application (2021-2032) Figure 22. Global General Anesthetics Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global General Anesthetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global General Anesthetics Revenue Market Share by Application (2021-2032) Figure 25. North America General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America General Anesthetics Sales Market Share by Country (2021-2032) Figure 27. U.S. General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe General Anesthetics Sales Market Share by Country (2021-2032) Figure 32. Germany General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 33. France General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific General Anesthetics Sales Market Share by Country (2021-2032) Figure 39. China General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 43. India General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa General Anesthetics Sales Market Share by Country (2021-2032) Figure 47. Brazil General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile General Anesthetics Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global General Anesthetics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global General Anesthetics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 58. North America General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 60. Europe General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. General Anesthetics Value Chain Figure 66. Manufacturing Cost Structure Figure 67. General Anesthetics Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Inhalation Anesthestic
  • Intravenous Anesthestic
Applications
  • Hospital
  • Ambulatory Surgery Center
  • Others
Companies covered
  • Eisai
  • Johnson & Johnson
  • Merck
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • GlaxoSmithKline
  • Fresenius Kabi AG
  • Baxter International
  • AbbVie
  • AstraZeneca
  • Lannett
  • Hikma Pharmaceuticals
  • Endo International
  • Boehringer Ingelheim
  • B. Braun Melsungen AG
  • Aspen Pharmacare
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global General Anesthetics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global General Anesthetics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global General Anesthetics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global General Anesthetics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global General Anesthetics Market Dynamics
  1. 2.1 General Anesthetics Industry Trends
  2. 2.2 General Anesthetics Industry Drivers
  3. 2.3 General Anesthetics Industry Opportunities and Challenges
  4. 2.4 General Anesthetics Industry Restraints
3 General Anesthetics Market by Manufacturers
  1. 3.1 Global General Anesthetics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global General Anesthetics Sales by Manufacturers (2021-2026)
  3. 3.3 Global General Anesthetics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global General Anesthetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global General Anesthetics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global General Anesthetics Manufacturers, Product Type & Application
  7. 3.7 Global General Anesthetics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global General Anesthetics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 General Anesthetics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 General Anesthetics Tier 1, Tier 2, and Tier 3
4 General Anesthetics Market by Type
  1. 4.1 General Anesthetics Type Introduction
  2. 4.1.1 Inhalation Anesthestic
  3. 4.1.2 Intravenous Anesthestic
  4. 4.2 Global General Anesthetics Sales by Type
  5. 4.2.1 Global General Anesthetics Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global General Anesthetics Sales by Type (2021-2032)
  7. 4.2.3 Global General Anesthetics Sales Market Share by Type (2021-2032)
  8. 4.3 Global General Anesthetics Revenue by Type
  9. 4.3.1 Global General Anesthetics Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global General Anesthetics Revenue by Type (2021-2032)
  11. 4.3.3 Global General Anesthetics Revenue Market Share by Type (2021-2032)
5 General Anesthetics Market by Application
  1. 5.1 General Anesthetics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Ambulatory Surgery Center
  4. 5.1.3 Others
  5. 5.2 Global General Anesthetics Sales by Application
  6. 5.2.1 Global General Anesthetics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global General Anesthetics Sales by Application (2021-2032)
  8. 5.2.3 Global General Anesthetics Sales Market Share by Application (2021-2032)
  9. 5.3 Global General Anesthetics Revenue by Application
  10. 5.3.1 Global General Anesthetics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global General Anesthetics Revenue by Application (2021-2032)
  12. 5.3.3 Global General Anesthetics Revenue Market Share by Application (2021-2032)
6 Global General Anesthetics Sales by Region
  1. 6.1 Global General Anesthetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global General Anesthetics Sales by Region (2021-2032)
  3. 6.2.1 Global General Anesthetics Sales by Region (2021-2026)
  4. 6.2.2 Global General Anesthetics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America General Anesthetics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe General Anesthetics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific General Anesthetics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa General Anesthetics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global General Anesthetics Revenue by Region
  1. 7.1 Global General Anesthetics Revenue by Region
  2. 7.1.1 Global General Anesthetics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global General Anesthetics Revenue by Region (2021-2026)
  4. 7.1.3 Global General Anesthetics Revenue by Region (2027-2032)
  5. 7.1.4 Global General Anesthetics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America General Anesthetics Revenue (2021-2032)
  8. 7.2.2 North America General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe General Anesthetics Revenue (2021-2032)
  11. 7.3.2 Europe General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific General Anesthetics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa General Anesthetics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai General Anesthetics Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson General Anesthetics Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck General Anesthetics Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Jiangsu Hengrui Pharmaceutical Co., Ltd.
  20. 8.4.1 Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Jiangsu Hengrui Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Product Portfolio
  24. 8.4.5 Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline General Anesthetics Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Fresenius Kabi AG
  32. 8.6.1 Fresenius Kabi AG Company Information
  33. 8.6.2 Fresenius Kabi AG Business Overview
  34. 8.6.3 Fresenius Kabi AG General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi AG General Anesthetics Product Portfolio
  36. 8.6.5 Fresenius Kabi AG Recent Developments
  37. 8.7 Baxter International
  38. 8.7.1 Baxter International Company Information
  39. 8.7.2 Baxter International Business Overview
  40. 8.7.3 Baxter International General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Baxter International General Anesthetics Product Portfolio
  42. 8.7.5 Baxter International Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie General Anesthetics Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca General Anesthetics Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 Lannett
  56. 8.10.1 Lannett Company Information
  57. 8.10.2 Lannett Business Overview
  58. 8.10.3 Lannett General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lannett General Anesthetics Product Portfolio
  60. 8.10.5 Lannett Recent Developments
  61. 8.11 Hikma Pharmaceuticals
  62. 8.11.1 Hikma Pharmaceuticals Company Information
  63. 8.11.2 Hikma Pharmaceuticals Business Overview
  64. 8.11.3 Hikma Pharmaceuticals General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals General Anesthetics Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals Recent Developments
  67. 8.12 Endo International
  68. 8.12.1 Endo International Company Information
  69. 8.12.2 Endo International Business Overview
  70. 8.12.3 Endo International General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Endo International General Anesthetics Product Portfolio
  72. 8.12.5 Endo International Recent Developments
  73. 8.13 Boehringer Ingelheim
  74. 8.13.1 Boehringer Ingelheim Company Information
  75. 8.13.2 Boehringer Ingelheim Business Overview
  76. 8.13.3 Boehringer Ingelheim General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim General Anesthetics Product Portfolio
  78. 8.13.5 Boehringer Ingelheim Recent Developments
  79. 8.14 B. Braun Melsungen AG
  80. 8.14.1 B. Braun Melsungen AG Company Information
  81. 8.14.2 B. Braun Melsungen AG Business Overview
  82. 8.14.3 B. Braun Melsungen AG General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 B. Braun Melsungen AG General Anesthetics Product Portfolio
  84. 8.14.5 B. Braun Melsungen AG Recent Developments
  85. 8.15 Aspen Pharmacare
  86. 8.15.1 Aspen Pharmacare Company Information
  87. 8.15.2 Aspen Pharmacare Business Overview
  88. 8.15.3 Aspen Pharmacare General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Aspen Pharmacare General Anesthetics Product Portfolio
  90. 8.15.5 Aspen Pharmacare Recent Developments
  91. 8.16 Abbott Laboratories
  92. 8.16.1 Abbott Laboratories Company Information
  93. 8.16.2 Abbott Laboratories Business Overview
  94. 8.16.3 Abbott Laboratories General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Abbott Laboratories General Anesthetics Product Portfolio
  96. 8.16.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 General Anesthetics Value Chain Analysis
  2. 9.1.1 General Anesthetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 General Anesthetics Production Mode & Process
  6. 9.2 General Anesthetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 General Anesthetics Distributors
  9. 9.2.3 General Anesthetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst